Adbry 50222-0346
Generic: Tralokinumab-Ldrm
Product NDC
50222-0346- Manufacturer
- Leo Pharma Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 2, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA761180
Need to source Adbry? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tralokinumab | 150 mg/mL |
Drug Class
Interleukin-13 Antagonist [EPC]Interleukin-13 Antagonist [EPC]Interleukin-13 Antagonists [MoA]
Packaging Options(3)
2 SYRINGE, GLASS in 1 CARTON (50222-346-02) / 1 mL in 1 SYRINGE, GLASS (50222-346-01)
2 CARTON in 1 CARTON (50222-346-04) / 2 SYRINGE, GLASS in 1 CARTON (50222-346-22) / 1 mL in 1 SYRINGE, GLASS (50222-346-01)
2 SYRINGE, GLASS in 1 CARTON (50222-346-92) / 1 mL in 1 SYRINGE, GLASS (50222-346-91)